company profile
Xiamen Ruijie Tianchuan Biotechnology Co., Ltd. focuses on the cell industry and focuses on innovative research. It mainly carries out the following projects: the construction of human genetic resources tissue cell bank, the clinical research and development and production of stem cells and immune cells, and the research and development and production of cellular biological agents; Actively promote the clinical research, technology development and market transformation of the cell industry, strive to build an international first-class and domestic leading cell R & D and production center, and become a leading well-known enterprise in the industry.
At present, the enterprise has built GMP cell production workshop, GMP nucleic acid production workshop, GMP biological product production workshop, P2 level laboratory, R & D laboratory, biological sample storage center, biological information center, quality control center, etc.
Xiamen Ruijie Tianchuan Biotechnology Co., Ltd. has a Shandong R & D and production base (Shandong Tianchuan precision medical technology Co., Ltd.), which has obtained the following qualifications: national high-tech enterprise, Dezhou Key Laboratory of stem cells and biological therapy, Dezhou (Tianchuan) regional cell preparation center, and Dezhou enterprise technology center. In addition, it has offices in Jinan, Taiyuan and other cities.
Platform projects built by the company
Tissue and cell bank of human genetic resources
It mainly stores umbilical cord, placental stem cells, umbilical cord blood stem cells of newborns, and various stem cells and immune cells of adults.
By the end of 2021, the population of Fujian was 41.87 million, the birth rate was 8.26 ‰, and the number of newborns was 345000. Referring to the stem cell storage charges in other provinces, each stem cell sample is calculated at 20000 yuan, and the directly corresponding stem cell storage market scale in the province is 6.7 billion yuan. Even if one tenth of the market share can be obtained, the market scale is more than 670 million.
Promoting the construction of the cell bank in the province and the city can not only save the local genetic resources nearby, improve the safety and effectiveness of the samples, promote the development of the cell industry in the province and the city, but also keep the tax of this income in the province or the city.
Regional cell preparation center
Stem cell and immune cell therapy is the development direction of medicine, and has achieved great success so far. Biological therapy has become a new revolution in the medical field. Because the cells are not convenient for long-distance transportation, the local patients who need cell therapy go to other cities and provinces for treatment.
Therefore, the construction of a large-scale cell processing and preparation center (producing and developing various cell products, including stem cells and immune cells) with national unified standards in this region is not only an important livelihood project, but also a huge market scale, which can radiate medical institutions, scientific research institutions and related enterprises in this province and surrounding provinces and cities. It can provide research level, clinical level, traceable cell products, reliable cell resources and related technical services of "on-demand preparation", taking into account the diversity of individual treatment needs, the scale of production and preparation and the convenience of supervision and management.
On this platform, our company mainly carries out clinical R & D and market transformation of immune cells to promote the development of cellular drugs in Xiamen, especially car-t and car-nk cells targeted for cancer treatment.
R & D and production center of cellular biological agents
The center is mainly used for the production, research and development, and preparation of biological agents related to the cell industry, including various protein cytokines such as interleukin (IL), interferon (IFN), tumor necrosis factor (TNF) required in the process of cell culture, as well as various antibody products required in the cell industry. At the same time, the region undertakes the research and development and production of relevant detection kits required in the cell industry.
Construction significance
-
1. In line with the development direction of the province
On April 21 this year, the provincial government issued the implementation plan for accelerating the high-quality development of the biomedical industry in Fujian Province, which proposed that "the biomedical industry is one of the most active and rapidly developing fields in the modern industry and is a new growth point of strategic emerging industries in Fujian Province", "Focus on building a biomedical industry highland in Xiamen".
2. In terms of economic benefits, social benefits and Local Taxation
Excellent results can be achieved. As mentioned above, only in terms of stem cell storage, one tenth of the market share of Fujian Province corresponds to the market scale of 670 million yuan, and will increase year by year.
3. People's livelihood
The development and clinical application of cell therapy technology can improve the sub-health status, improve the health level of the whole people, improve the cure rate of major diseases, reduce the mortality rate of major diseases, and improve the comprehensive level of genetic diseases and major diseases in Xiamen.
4. Promote the formation of industrial chain
The project is a high-tech industry. Its implementation and the formation of its related industrial chain can attract high-quality talents and improve the industrial technology level.
